In the US, Apidra (insulin glulisine systemic) is a member of the drug class insulin and is used to treat Diabetes - Type 1, Diabetes - Type 2, Diabetic Ketoacidosis and Nonketotic Hyperosmolar Syndrome.
Ingredient matches for Apidra
Insulin Glargine is reported as an ingredient of Apidra in the following countries:
Insulin Glulisine is reported as an ingredient of Apidra in the following countries:
- Bosnia & Herzegowina
- Costa Rica
- Dominican Republic
- El Salvador
- Hong Kong
- New Zealand
- Russian Federation
- South Africa
- United Kingdom
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.